Mark Bernauer, BPharm is a Senior Scientist in Strategic Market Access group, located in Pharmerit’s Bethesda, MD office. He has more than 25-years of experience across a breadth of roles including medical functions within the pharmaceutical industry, as a healthcare consultant, and as a registered pharmacist. His expertise includes medical writing (e.g., systematic and targeted literature reviews, manuscript development, and global and AMCP product-value dossiers), communication and evidence generation plans, market access recommendations, value propositions, and conducting competitor and stakeholder analyses. Mark has therapeutic experience in the following areas: neurology, dermatology, endocrinology, immunology, oncology, pulmonology, ophthalmology, and infectious disease.
Prior to joining Pharmerit, Mark worked within the consulting industry at Precision Health Economics and Optum across a variety of medical writing/market access projects. Mark also worked in the pharmaceutical industry at Eli Lilly and Company in Indianapolis, IN, primarily supporting the neuroscience portfolio, across a breadth of roles including health economics and outcomes research, medical sourcing, clinical plans and operations, and medical information. Mark has been responsible for creating and publishing over 15 manuscripts, conducting 50 plus literature reviews, and creating over 25 dossiers. Additionally, Mark served and led projects on the AMCP special projects committee. Mark earned his Bachelor of Pharmacy degree from the University of Wisconsin.